HomeTagsCordenPharma

Tag: CordenPharma

The global peptide capacity race:...

The rapid growth of the GLP-1 drug...

The global peptide capacity race: who is investing in GLP-1 manufacturing?

The rapid growth of the GLP-1 drug market is driving a major expansion of global peptide manufacturing capacity. Pharmaceutical companies are investing in their own production networks, while contract development and manufacturing organisations (CDMOs) are building new facilities, acquiring specialist manufacturers and upgrading existing sites. Not all announced projects are dedicated exclusively to GLP-1 medicines. Several investments concern broader peptide manufacturing platforms that may also support GLP-1-related programmes, depending on customer demand, process requirements and available capacity. The investment pipeline spans North America, Europe and Asia. It includes large-scale peptide active...

The global peptide...

The rapid growth of the GLP-1 drug market is driving a major expansion of global peptide manufacturing capacity. Pharmaceutical companies are investing in their...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!